# Efficacy of IV Palo With IV Dexamethasone vs IV Palo for Prevention of Immediate & Delayed PONV

> **NCT00952133** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 118 (actual)

## Conditions studied

- PONV

## Interventions

- **DRUG:** Palonosetron only
- **DRUG:** Palonosetron with Dexamethasone

## Key facts

- **NCT ID:** NCT00952133
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-07
- **Final completion:** 2011-04
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2015-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00952133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00952133, "Efficacy of IV Palo With IV Dexamethasone vs IV Palo for Prevention of Immediate & Delayed PONV". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00952133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*